Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025

Presenting Author: Andrew T. Kuykendall, M.D. (Moffitt Cancer Center)

Title: Results From VERIFY, a Phase 3, Double-Blind, Placebo (PBO)-Controlled Study of Rusfertide for Treatment of Polycythemia Vera (PV)

Abstract: LBA3

Session Name: Plenary Session
Session Date: 
Sunday, June 1, 2025
Presentation Time: 
2:09 PM - 2:21 PM CDT
Location: 
McCormick Place, Hall B1